Drreddys Laboratories reported INR574.48B in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
ANI Pharmaceuticals USD 1.57B 73.55M Sep/2026
Aurora Cannabis CAD 620.88M 19.79M Jun/2026
Bayer EUR 113.47B 6.18B Sep/2026
Canopy Growth CAD 1.1B 14.81M Jun/2026
Cipla INR 434.34B 9.38B Sep/2026
Corcept Therapeutics USD 1.03B 145.32M Sep/2026
Drreddys Laboratories INR 574.48B 4.86B Sep/2026
GlaxoSmithKline GBP 71.7B 9.96B Sep/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Lonza CHF 18.97B 164M Dec/2025
Novartis USD 117.15B 4.88B Sep/2026
Pacira USD 34.68B 33.44B Sep/2026
Phibro Animal Health USD 1.51B 13.48M Sep/2026
Prestige Brands USD 4.72B 153.09M Sep/2026
Richter Gedeon HUF 1.69T 70.26B Jun/2026
Sun Pharmaceuticals INR 1.15T 60.53B Sep/2026
Supernus Pharmaceuticals USD 1.4B 30.42M Sep/2026
Teva Pharmaceutical Industries USD 40.04B 185M Sep/2026